Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesBeginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Prestige Consumer Healthcare (PBH) Change in Cash: 2010-2025

Historic Change in Cash for Prestige Consumer Healthcare (PBH) over the last 16 years, with Sep 2025 value amounting to -$20.4 million.

  • Prestige Consumer Healthcare's Change in Cash fell 218.01% to -$20.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $67.6 million, marking a year-over-year increase of 892.38%. This contributed to the annual value of $51.4 million for FY2025, which is 527.75% up from last year.
  • Per Prestige Consumer Healthcare's latest filing, its Change in Cash stood at -$20.4 million for Q3 2025, which was down 149.01% from $41.6 million recorded in Q2 2025.
  • In the past 5 years, Prestige Consumer Healthcare's Change in Cash ranged from a high of $131.3 million in Q2 2021 and a low of -$120.8 million during Q3 2021.
  • Moreover, its 3-year median value for Change in Cash was -$666,000 (2024), whereas its average is $3.0 million.
  • Its Change in Cash has fluctuated over the past 5 years, first skyrocketed by 456.67% in 2021, then plummeted by 551.91% in 2023.
  • Quarterly analysis of 5 years shows Prestige Consumer Healthcare's Change in Cash stood at -$21.8 million in 2021, then spiked by 301.45% to $43.9 million in 2022, then plummeted by 91.92% to $3.5 million in 2023, then plummeted by 118.77% to -$666,000 in 2024, then tumbled by 218.01% to -$20.4 million in 2025.
  • Its Change in Cash was -$20.4 million in Q3 2025, compared to $41.6 million in Q2 2025 and $47.0 million in Q1 2025.